Clinical trial
Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage
NCT05369351 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage
- Lead sponsor
- Tianjin Medical University General Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 17, 2024
- Completion date
- November 10, 2026
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intracerebral haemorrhage